Sam Altman’s September 2026 statements that an OpenAI IPO would be “ill-advised” this year due to the need for stronger AI safety and alignment claims have become the dominant driver of trader sentiment. The company confidentially filed its S-1 in June with an original September target, but CFO Sarah Friar and Altman both pointed to 2027, citing the requirement to demonstrate credible safety progress on frontier large language models before facing public-market scrutiny. OpenAI is instead pursuing additional private capital at valuations near or above $1.4 trillion while its revenue run rate approaches $50 billion, reducing near-term pressure to list. Key upcoming catalysts include any concrete safety benchmarks or partnerships that could accelerate the timeline, alongside potential moves by competitors like Anthropic that might reset market expectations for AI company IPO sequencing.